Patents by Inventor Daniela Corda

Daniela Corda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD TO IDENTIFY COMPOUNDS ABLE TO BIND TO THE ROSSMANN FOLD OF C-TERMINAL-BINDING PROTEINS, IDENTIFIED COMPOUNDS AND MEDICAL USES THEREOF
    Publication number: 20170003275
    Abstract: The invention refers to a method for identifying an anti-tumoral and/or anti-proliferative and/or an inhibitor of the fission machinery involved in mitotic Golgi partitioning and/or a molecule modulator of CtBP corepressor activity by testing their affinity binding for the Rossmann fold of C-terminal-binding proteins (CtBPs); to said identified molecules and to the use thereof as anti-proliferative and/or anti tumoral agents.
    Type: Application
    Filed: May 16, 2014
    Publication date: January 5, 2017
    Inventors: Antonino COLANZI, Alberto LUINI, Daniela CORDA
  • Use of glycerophosphoinositols for the treatment of septic shock
    Patent number: 9351983
    Abstract: The present invention refers to glycerophosphoinositols (GPIs) and derivatives thereof for use in the treatment of pathologies related to a Lipopolysaccharide (LPS)-activated tissue-factor (TF) activity, as pathologies induced by high bacteremia, i.e. septic shock.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: May 31, 2016
    Assignee: CONSIGLIO NAZIONALE DELLE RICERCHE
    Inventors: Daniela Corda, Pasquale Zizza, Alberto Luini, Stefania Mariggio'
  • USE OF GLYCEROPHOSPHOINOSITOLS FOR THE TREATMENT OF SEPTIC SHOCK
    Publication number: 20150272971
    Abstract: The present invention refers to glycerophosphoinositols (GPIs) and derivatives thereof for use in the treatment of pathologies related to a Lipopolysaccharide (LPS)-activated tissue-factor (TF) activity, as pathologies induced by high bacteremia, i.e. septic shock.
    Type: Application
    Filed: October 4, 2013
    Publication date: October 1, 2015
    Inventors: Daniela Corda, Pasquale Zizza, Alberto Luini, Stefania Mariggio'
  • Glycerophosphoinositol derivatives as modulators of cytosolic A2 phospholipase
    Patent number: 7625883
    Abstract: Optionally O-substituted glycero-phosphoinositol derivatives, their analogues and their salts wherein the substitutents: R?1, R?2, R2, R3, R4, R5, R6 have the described meaning, their synthesis and their pharmacological effect as modulators of the activation or over-stimulation of cPLA2.
    Type: Grant
    Filed: November 7, 2000
    Date of Patent: December 1, 2009
    Assignee: I.R.B. Istituto di Ricerche Biotechnologiche S.R.L.
    Inventors: Daniela Corda, Roberto Dal Toso, Giovanna Bonvento, Gabriele Marcolongo, Renzo Dal Monte